A549 host cells comprising a recombinant oncolytic adenovirus with modified E1A cancer-specific promoter
US12291726B2 · kind B2 · utility
0Cited by
2References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 29, 2024 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Apr 29, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/10352
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure relates to compositions and methods for producing a recombinant virus, e.g., a recombinant oncolytic adenovirus, using an A549 host cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.